Overview

Sirolimus and Cetuximab in Advanced Malignancies

Status:
Completed

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to find the highest tolerable dose of the combination of sirolimus and cetuximab that can be given to patients with advanced cancer. The safety of this drug combination will also be studied.

Phase:

Phase 1

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Cetuximab
Everolimus
Sirolimus